Toggle Search
Toggle Menu

Our Mentors

Alisa Valudes Whyte

SVP and Partner, Merritt Group

LinkedIn

Charles Gold

Founder, C. Gold Strategic Marketing

LinkedIn

Charles J. Andres Jr., J.D., Ph.D., RAC

Associate, Wilson, Sonsini, Goodrich & Rosati

LinkedIn

Danielle Winston

Associate, Crowell & Moring LLP

LinkedIn

Dr. Raymond Thal

Orthopaedic Surgeon, Inova

LinkedIn

Eric Claude

Vice President, Product Development, MPR Associates

LinkedIn

G Scott Shaw

President and Founder, Everclear Marketing

LinkedIn

George Siragusa

Senior Business Consultant and Senior Partner, Inline Marketing Partners

LinkedIn

Jane-Scott Cantus

Managing Principal, Strategic Services and General Counsel, The ILEX Group

LinkedIn

Jay Gamble

Co-Founder and Managing Principal, Blu Ventures Investors

LinkedIn

Jeff Champagne

Director of Business Development, MPR Associates

LinkedIn

Jonathan Chashper

CEO and Founder, Product Savvy Consulting

LinkedIn

Kristian Marquez, CFA

Managing Principal, FinStrat Management LLC

LinkedIn

Lex Eley

Partner, Crowell & Moring LLP

LinkedIn

Matt Donovan

Senior Vice President, Merritt Group

LinkedIn

Melissa Walker

Founder, President and CTO, Graematter

LinkedIn

Michael Cheney

VP Marketing, Oakenshaw Resources, LLC

LinkedIn

Neil Kleinberg

Founder and CEO, DiliVer

LinkedIn

Teresa Goody

Founder and CEO, The Goody Group

LinkedIn

Todd Leto

CEO, Hememics

LinkedIn

What's Happening

Jonathan Aberman: What do investors like about investing in D.C.? I asked them.

Nov 02, 2018

“We often talk about how important it is to attract more investors to our region, so I asked some... Read More

Why a DC Area Health System Is Training Tech Entrepreneurs – A Q&A with Rick Gordon of Inova

Oct 23, 2018

As published on the The Corporate Growth…Capital Style blog on October 22, 2018 by Ryan Schradin This Thursday (October 25, 2018), the... Read More

The Squeeze Continues…Early Stage Health Tech Deal Volume Falls to New Lows

Oct 15, 2018

by Michael Thomas Five consecutive quarters—and counting—of declining deal counts in pre-seed and seed-level investments for health technology startups... Read More